Elliot S. Bishop

ORCID: 0000-0002-6832-2001
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Wound Healing and Treatments
  • Trauma Management and Diagnosis
  • Virus-based gene therapy research
  • Mesenchymal stem cell research
  • Bone Tissue Engineering Materials
  • Cancer Research and Treatments
  • Pluripotent Stem Cells Research
  • Pleural and Pulmonary Diseases
  • Uterine Myomas and Treatments
  • Electrospun Nanofibers in Biomedical Applications
  • Case Reports on Hematomas
  • Diabetic Foot Ulcer Assessment and Management
  • Monoclonal and Polyclonal Antibodies Research
  • Graphene and Nanomaterials Applications
  • Viral Infectious Diseases and Gene Expression in Insects
  • Cardiac Arrest and Resuscitation
  • Additive Manufacturing and 3D Printing Technologies
  • Streptococcal Infections and Treatments
  • RNA Interference and Gene Delivery
  • 3D Printing in Biomedical Research
  • Planarian Biology and Electrostimulation
  • Pneumothorax, Barotrauma, Emphysema
  • Periodontal Regeneration and Treatments

Grady Memorial Hospital
2023

Jackson Health System
2021

University of Miami
2021

University of Chicago
2017-2020

University of Chicago Medical Center
2017-2019

Molecular Oncology (United States)
2017-2019

With rapid advances in understanding molecular pathogenesis of human diseases the era genome sciences and systems biology, it is anticipated that increasing numbers therapeutic genes or targets will become available for targeted therapies. Despite numerous setbacks, efficacious gene and/or cell-based therapies still hold great promise to revolutionize clinical management diseases. It wildly recognized poor delivery limiting factor most vivo There has been a long-lasting interest using viral...

10.1016/j.gendis.2017.04.001 article EN cc-by-nc-nd Genes & Diseases 2017-04-27

Advances in three-dimensional (3D) printing have increased feasibility towards the synthesis of living tissues. Known as 3D bioprinting, this technology involves precise layering cells, biologic scaffolds, and growth factors with goal creating bioidentical tissue for a variety uses. Early successes demonstrated distinct advantages over conventional engineering strategies. Not surprisingly, there are current challenges to address before bioprinting becomes clinically relevant. Here we provide...

10.1016/j.gendis.2017.10.002 article EN cc-by-nc-nd Genes & Diseases 2017-11-23

Effective bone tissue engineering is important to overcome the unmet clinical challenges as more than 1.6 million grafts are done annually in United States. Successful needs minimally three critical constituents: osteoprogenitor cells, osteogenic factors, and osteoinductive/osteoconductive scaffolds. Osteogenic progenitors derived from multipotent mesenchymal stem cells (MSCs), which can be prepared numerous sources, including adipose tissue. We previously showed that BMP9 most BMP induces...

10.1021/acsbiomaterials.8b00179 article EN publisher-specific-oa ACS Biomaterials Science & Engineering 2018-06-07

Due to availability and ease of harvest, adipose tissue is a favorable source progenitor cells in regenerative medicine, but has yet be optimized for osteogenic differentiation. The purpose this study was test cranial bone healing surgical defect model utilizing morphogenetic protein-9 (BMP-9) transduced immortalized murine adipocyte (iMAD) citrate-based, phase-changing, poly(polyethylene glycol citrate-co-N-isopropylacrylamide) (PPCN)-gelatin scaffold. Mesenchymal iMAD were with adenovirus...

10.1097/scs.0000000000005465 article EN Journal of Craniofacial Surgery 2019-03-25

10.1097/00000441-190212000-00059 article EN The American Journal of the Medical Sciences 1902-12-01

Pocivavsek, Luka MD, PhD; Bishop, Elliot MD; Khabaz, Kameel; Ota, Takeyoshi Skelly, Christopher FACS; Hampton, David MEngAuthor Information

10.1097/ta.0000000000002904 article EN Journal of Trauma and Acute Care Surgery 2020-08-30

Objective There is a need for cancer imaging in the clinic and operating room. We have shown that fluorescently labeled antibodies can detect microscopic islands of head neck cells using modified intraoperative microscopes preclinical animal studies. Here we evaluated optimal targeting molecule clinical translation. Method assessed vitro binding EGFR (cetuximab/Erbitux panitumumab/Vectibix) an antibody mimetic (anti‐EGFR affibody) multiple cell lines (SCC5, OSC19, FADU). To compare vivo...

10.1177/0194599811416318a100 article EN Otolaryngology 2011-08-01
Coming Soon ...